Logo Logo
Hilfe
Hilfe
Switch Language to English

Schaefer, Martin; Sarkar, Susanne; Schwarz, Markus und Friebe, Astrid (2016): Soluble Intracellular Adhesion Molecule-1 in Patients with Unipolar or Bipolar Affective Disorders. Results from a Pilot Trial. In: Neuropsychobiology, Bd. 74, Nr. 1: S. 8-14 [PDF, 111kB]

[thumbnail of Soluble_Intracellular_Adhesion_Molecule-1_in_Patients_with_Unipolar_or_Bipolar_Affective_Disorders.pdf]
Vorschau
Download (111kB)

Abstract

Background: Immunological and vascular markers may play a role in the pathophysiology of mood disorders and mood changes. Aim: To test whether the cell adhesion molecule soluble intracellular adhesion molecule-1 (sICAM-1) may serve as a biomarker for patients with unipolar or bipolar affective disorders when compared to a healthy control group, and whether sICAM-1 blood levels change during different mood states. Methods: sICAM-1 serum concentrations were compared between 20 healthy controls and 48 patients with affective disorders (unipolar, bipolar II and bipolar I disorder) during different mood states (euthymic mood state, depression or mania). Results: When compared to healthy controls, patients with affective disorders had significantly higher sICAM-1 levels during the euthymic state (p = 0.015). Differences became more pronounced during depression (p = 0.013). When unipolar and bipolar patients were analyzed separately, unipolar patients significantly differed from controls during the euthymic and depressive mood state, while bipolar II patients showed a trend towards higher sICAM-1 levels during depression. Patients with bipolar I disorders had significantly higher sICAM-1 levels during manic states when compared to controls (p = 0.007). Conclusions: sICAM-1 elevation in unipolar and bipolar patients, independent of mood changes, might support the hypothesis of chronic immune activation and endothelial dysfunction in patients with affective disorders. (C) 2016 S. Karger AG, Basel

Dokument bearbeiten Dokument bearbeiten